ACA App
Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia
Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Submission | Subscribe | Advertise | Contact | Login 
Users online: 628 Small font size Default font size Increase font size Print this article Email this article Bookmark this page
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone, administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs

Sidi Avner, Muehschlegel Jochen D, Kirby David S, Lobato Emilio B

Year : 2007| Volume: 10| Issue : 1 | Page no: 34-41

   This article has been cited by
 
1 ORM-3819 promotes cardiac contractility through Ca2+ sensitization in combination with selective PDE III inhibition, a novel approach to inotropy
László Nagy,Piero Pollesello,Heimo Haikala,Ágnes Végh,Tia Sorsa,Jouko Levijoki,Szabolcs Szilágyi,István Édes,Attila Tóth,Zoltán Papp,Julius Gy. Papp
European Journal of Pharmacology. 2016;
[Pubmed]  [Google Scholar] [DOI]